Temi della conferenza The spotlight continues to shine on lipid nanoparticles as the 'go-to' delivery vehicle, however the demand remains to translate learnings from vaccine LNP-mRNA success into therapeutic applications. Positioned as a delivery vehicle with no ceiling to innovation, drug developers across the field are continuing to progress research to target the previously unreachable and treating the undruggable.
Speakers: Alexander Kros, Professor, Leiden University, Christian Plank, Chief Technology Officer, Ethris, Daniel Tondera, Head of Biology, Pantherna Therapeutics, and more
